News: New Bespoke Gene Therapy Consortium Is Welcome Development

The creation of the Bespoke Gene Therapy Consortium (BGTC) in the US is welcome news, especially if it achieves its ambition to accelerate the delivery of more gene therapies for rare diseases. The new body is headed and funded by FDA and the National Institutes of Health (NIH), with other stakeholders including small biotechs, major pharma brands, and non-profit organizations. 

Read more…

Conference: 2nd Multi-Functional Cell Therapies Summit

The future of cell therapies is multi-faceted. The 2nd Multi-Functional Cell Therapies Summit is returning 25-27 January 2022, uniting pioneers at the forefront of development to discuss the next generation of cell therapies, which boast safer, more efficacious targeting profiles.

Join the only cell-type agnostic, targeting focused meeting, overcome challenges to weaponizing cell therapies against solid tumors and join global innovators to

• Understand the immunosuppressive nature of the TME to inform future drug development
• Exploit multiple functions through innovative engineering and novel targeting approaches to produce “smarter” cell therapies with high efficacy and safety profiles
• Synergize analytical strategy with efficient and standardized manufacturing to overcome regulatory barriers preventing approval.

Register now…

Conference: 5th Antigen-Specific Immune Tolerance Summit

There continues to be ongoing investment into the development of novel antigen-specific immunotherapies as Novartis collaborates with Cellerys, and Moderna pioneers an mRNA approach into autoimmune diseases. The 5th Antigen-Specific Immune Tolerance Summit, 26-27 January 2022, is your definitive industry-dedicated forum to harness the power of T-cell therapies to induce antigen-specific immune tolerance and lean into the translational challenges and supercharge life-changing antigen-specific immunotherapies into the clinic and to patients in need.
Connect with 80+ industry leaders and be discuss:
• Examining the mechanisms underlying tolerance induction to drive antigen and epitope discovery with insights from the NIH, Vaccibody, and Imcyse
• Leveraging immune biomarkers and exploring immune tolerance in diabetes with Novo Nordisk, COUR Pharmaceuticals, and Diamyd Medical
• Exploring the diversity of technologies and platforms for antigen delivery with Toleranzia, Allero Therapeutics, Idogen AB, and AnTolRx, Inc
• Optimizing clinical durability and efficacy of antigen-specific immunotherapies with insights from WORG Pharmaceuticals, and Cellerys

Access the complete agenda here.
With a plethora of drugs poised to enter the early-stage clinical testing in 2022, this is your opportunity to further your understanding and translate durable and efficacious therapies into the clinic. 

Register now…

Conference: Formulation & Delivery US: In-Person 

Join a world-class panel of leading pharmaceutical development professionals at Oxford Global’s Formulation & Drug Delivery USA Congress, 1-2 February 2022. With drug delivery and formulation critical to commercial success, this congress addresses both these areas in relation to small and large molecules, giving you critical insight into the latest industry trends.   

This congress will focus on industry topics such as new strategies for Nano & RNA-based formulation and delivery, novel formulation strategies for small molecules and advances in small molecule and biologics drug delivery. Attendees can expect to benefit from case study and best practice style presentations from leading companies such as Pfizer, Novartis, Takeda, and AstraZeneca. Putting you in contact with over 300 senior level delegates, this is the event for professionals looking to network and debate with leading professionals in the field.   
 

Register now…

Conference: RNA Therapeutics event

The RNA therapeutics industry has grown at an exponential rate in recent years, with an increased spotlight following the industry’s leading role in developing vaccines against COVID-19 in response to the global pandemic. This year’s conference will reflect on how the industry has adapted and played a pivotal role in global health over the past year and will discuss the takeaways for future mRNA therapeutic development.

The 2022 agenda will explore innovations in novel and targeted delivery, RNAi innovations and antisense oligonucleotide therapeutics. Global experts from big pharma and leading biotechs will explore the emerging therapeutic applications of RNA with case studies on the treatment of cardiovascular disease, neurological diseases, and oncology.

Join us 9-10 February 2022, as SMi’s 13th annual RNA Therapeutics Conference brings together industry experts from leading RNA therapeutics companies to gain an expert and holistic view on the latest developments of the industry.
 

Register now…

Conference: 4th Bacteriophage Therapy Summit

Returning for its 4th year, the Bacteriophage Therapy Summit, 14-16 February 2022,remains the comprehensive global forum providing exclusive insights to radically transform your bacteriophage therapies into commercially viable products.

2022 Agenda at a Glance:

• Navigate clinical trial rationale, distribution effects of formulation on reaching infection sites, lessons learned from compassionate use trials, and the regulatory pathway for commercial development with the hottest insights from our 35+ expert speaker faculty
• Hear from international organizations including the FDA, BiomX, Locus Bioscience, Felix Bioscience, Phagomed, PhagePro, Cytophage, Sciphage and unite with the phage community prioritizing human health and disease
• Discuss strategies to weaponize phage therapies including lysins, genetic engineered and combination approaches to create new pathways for the treatment of infectious diseases, across 3 days of unparalleled, industry-centered content
• Keep your company’s interest in bacteriophage therapies up-to-date and aligned with the new breakthroughs beyond basic science and establish your pathway to commercialization in 2022 and beyond.

See our full speaker faculty, all agenda topics and our attending audience in our event brochure: https://ter.li/7mczdc

Register now…

Conference: Genetic Vaccine Analytical Development Summit

As vaccine developers strive to ensure that the entire vaccine development process is as efficient, precise, and cost-effective as possible, the inaugural Genetic Vaccine Analytical Development Summit (15-17 February 2022) will unite large pharma and innovative biotechs to develop the right analytical methods to guarantee the quality, safety, and consistency of mRNA, DNA and viral vector-based vaccines.

Focused specifically on addressing the unique analytical challenges posed by genetic vaccines, this technical scientific conference will unite analytical scientists, Heads of CMC, Analytical Development, and Pre-Formulation from the leading companies grappling with these challenges first-hand.

Download the event guide to learn more.

Join the leading minds in vaccine analytics to optimize the development of better and more robust tools to ensure the safety, quality, and consistency of mRNA, DNA, and viral vector-based vaccines.
 

Register now…

Upcoming conferences and meetings

• 12 - 13 January 2022 - Pre-filled Syringes and Injectable Drug Devices, Cell & gene therapy - London, UK
• 18 - 20 January 2022 - Allogeneic Cell Therapies Summit Europe - London, UK
• 25 - 27 January 2022 - 2nd Multi-Functional Cell Therapies Summit - Online event
• 25 - 27 January 2022 - 2nd TGF-β for Immuno-Oncology Drug Development Summit - Online event
• 26 - 27 January 2022 - 5th Antigen-Specific Immune Tolerance Summit - Cell therapy approaches - Online event
• 1 - 2 February 2022 - Formulation & Delivery US: Gene and Cell Therapies - San Diego, CA
• 9 - 10 February 2022 - RNA Therapeutics event - London, UK
• 14 - 16 February 2022 - 4th Bacteriophage Therapy Summit - Online event
• 15 - 17 February 2022 - Genetic Vaccine Analytical Development Summit - Online event
• 22 - 24 February 2022 - Next Generation CAR-TCR Summit - London, UK
• 7 - 10 March 2022 - 5th Annual Gene Therapy for Rare Disorders - Boston, MA
• 9 - 11 March 2022, From Stem Cells and Genes to Therapies - Joint meeting with the AGCTS and ASSCR, Melbourne
• 22 - 24 March 2022 - Bioprocessing Summit Europe - Barcelona, Spain
• 28 - 30 March 2022 - Advancing Gene Therapy 2022 - Boston, MA
• 29 - 31 March 2022 - 3rd Gene Therapy for Blood Disorders Summit - Boston, MA
• 29 March - 1 April 2022 - 2nd Gene Therapy Comparability Summit - Boston, MA
• 6 – 8 April 2022 - Global Bioprocessing Summits - Cell & Gene therapy analytics - San Francisco, CA
• 4 – 7 April 2022 - 2nd Gene Therapy for Muscular Disorders Summit - Boston, MA
• 13 – 15 April 2022 - European Society of Gene and Cell Therapy (ESGCT) Spring School - Athens, Greece
• 19 – 21 April 2022, 2nd Gene Therapy Medical Affairs Summit, Boston, MA
• 21 - 22 April 2022 - Global Bioprocessing Summit - ATMP Development - Berlin, Germany
• 25 - 27 April 2022, 3rd Supply Chain and Logistics for Cell Therapies Summit, Boston, MA
• 11 – 13 May 2022 - Global Bioprocessing Summit Europe - Cell & Gene therapy analytics - Frankfurt, Germany
• 16 - 19 May 2022 - American Society of Gene and Cell Therapy (ASGCT) 25th Annual Meeting - Washington, D.C.
• 17 - 18 May 2022 - Advanced Therapies (ATMP) – Challenges for Routine Applications - Frankfurt am Main, Germany
• 13 - 17 June 2022 - 9th Monolith Summer Symposium, mRNA, Vaccines, Gene Therapy Vectors - Portoroz, Slovenia
• 11 – 14 October 2022 - XXIX Congress of the European Society of Gene and Cell Therapy (ESGCT) - Edinburgh, UK

Gene Therapy Net is the information resource for basic and clinical research in gene therapy, and the site serves as a network in the exchange of gene therapy information and breaking news items. Visitors can keep track of the latest scientific papers, conference announcements, gene therapy jobs, regulations and guidelines. Other information websites created and maintained by the owner of Gene Therapy Net are Dengue Virus Net, Influenza Virus Net, Ebola Virus Net, Chikungunya Virus Net, Zika Virus Net and Corona Virus Net.